Work

A novel age-informed approach for genetic association analysis in Alzheimer’s disease

Year: 2021
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Many Alzheimer's disease (AD) genetic association studies disregard age or incorrectly account for it, hampering variant discovery. METHODS: Using simulated data, we compared the statistical power of several models: logistic regression on AD diagnosis adjusted and not adjusted for age; linear regression on a score integrating case-control status and age; and multivariate Cox regression on age-at-onset. We applied these models to real exome-wide data of 11,127 sequenced individuals (54% cases) and replicated suggestive associations in 21,631 genotype-imputed individuals (51% cases). RESULTS: Modeling variable AD risk across age results in 5-10% statistical power gain compared to logistic regression without age adjustment, while incorrect age adjustment leads to critical power loss. Applying our novel AD-age score and/or Cox regression, we discovered and replicated novel variants associated with AD on KIF21B, USH2A, RAB10, RIN3, and TAOK2 genes. CONCLUSION: Our AD-age score provides a simple means for statistical power gain and is recommended for future AD studies.
Language: English
Open Access status: gold
Estimated APC paid: $3,490
Funders: U.S. Department of Defense, Foundation for the National Institutes of Health, U.S. Department of Health and Human Services, Alzheimer's Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Roche, Biogen, University of Southern California, Vanderbilt University, University of Miami, University of Pennsylvania, Meso Scale Diagnostics, Alzheimer's Disease Neuroimaging Initiative, BioClinica, University of Washington, Case Western Reserve University, Novartis Pharmaceuticals Corporation, Northern California Institute for Research and Education, Wellcome Trust, Broad Institute, EU Joint Programme – Neurodegenerative Disease Research, National Alzheimer's Coordinating Center, Texas Alzheimer's Research and Care Consortium, European Commission, ZonMw, Russian Foundation for Basic Research, Austrian Science Fund, Erasmus Medisch Centrum, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, University of Toronto, Eisai, Oesterreichische Nationalbank, Österreichische Forschungsförderungsgesellschaft, Karl-Franzens-Universität Graz, Medizinische Universität Graz, Servier, H. Lundbeck A/S, IXICO, National Institutes of Health, Genentech, Uniformed Services University of the Health Sciences, Canadian Institutes of Health Research, Medical Research Council, National Institute on Aging, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering, U.S. National Library of Medicine, H2020 Marie Skłodowska-Curie Actions
Awards: G1012222616, G1023702118, G1052397333, G1077033501, G1097528416, Epidemiologic Study of Neural Reserve and Neurobiology of Aging, G1218215880, G1243299691, G125972088, G1310852075, UC Davis Alzheimer's Disease Core Center, Indiana Alzheimer Disease Center, Genetic Studies of Dementia in the Amish, G1401438683, G1438302022, G1460387277, G1495020029, Genetic Epidemiology of Alzheimer's Disease in African Americans, G1527150935, G1575770996, G1575942645, G1614110324, G165438358, G1686058559, G1689944598, G1691174148, G1726490033, G173303992, G1734067475, G1857142429, G1942032999, G1952670415, CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample, Integrative translational discovery of vascular risk factors in aging and dementia, G1994508959, Large Scale Sequencing and Analysis of Genomes, Putting the Pieces Together: APOE, Age, Sex, and Ancestry in AD Genetics, G2098337849, G2178492673, G2383388692, G2404385439, University of Kentucky Alzheimer's Disease Core Center, G2423387114, G250621538, G2522063444, G2564988809, Neurobiology of Alzheimer's Disease and Aging, Gene discovery in PSP by transcriptome, neuropathology and sequence analysis, G2627750031, G2655596196, G270907595, G2715737188, G2778518020, G278200998, G2800149121, A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease, G2830398374, G2830784186, G2835601961, The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, G2899267414, A Platform for Large-Scale Genomic Discovery, G2929235049, G2990051238, G29951154, G3007488127, G301743239, G3021948349, Alzheimer's Disease Research Center, G3114902838, G3137375862, G3146424788, G3152385821, G3159755494, G3205625555, G3207356259, G3218891203, G3220743633, G322252321, Alzheimer's Disease Patient Registry (ADPR/ACT), National Alzheimer's Coordinating Center, UCSD Alzheimer's Disease Research Center P50, G34347772, eMERGE IV Northwest: A partnership to evaluate the use of genomic information in the health care of diverse participants, G3462919067, CHS research resources for the cardiovascular health of older adults, Alzheimer's Disease Research Center, Identification of Rare Variants in Alzheimer Disease, G3601031411, ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems, G3819938352, UCLA Alzheimer's Disease Research Center, G3834732120, G3839646794, G3870774570, G3882825079, G393177772, G3935527841, Consequences of Self-Neglect in a Biracial Population of Older People, G3966393351, Predictors of Alheimers Disease in Mild Cognitive Impairment, Risk Factors for Incident Alzheimer's Disease in a Biracial Community, G4119534169, G4167445418, G4196769506, G4200864717, G4219624527, G423252844, Alzheimer's Disease Core Center, G434337789, Cleveland Alzheimer's Disease Research Center, The Alzheimer's Disease Research Center at the University of California, Irvine, G4401988282, G4475667458, Replication and Extension of ADSP Discoveries in African-Americans, The Human Genome Sequencing Center, Stanford Alzheimer's Disease Research Center, G4577178459, G4599028518, G4622379297, ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5, G4685761485, European Network for Genetic and Genomic Epidemiology, G4828428735, G4860885537, G4871231843, Risk Factors, Pathology, and Clinical Expressions of AD, A multimodal approach to accelerate drug discovery and development in Alzheimer’s disease, Oregon Alzheimer's Disease Center, G494123624, G4942589162, G4970245363, G4986752099, G4998334444, ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5, Rush Alzheimer's Disease Core Center, Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts, G5053595415, G5074086979, G5145575165, Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS), G5251985303, G5258106493, Alzheimer's Disease Genetics Consortium, G5281659474, G5330437387, G5367426553, EFFECTS OF TRAUMATIC BRAIN INJURY (TBI) AND POST TRAUMATIC STRESS DISORDER (PTSD) ON ALZHEIMER'S DISEASE (AD) IN VETERANS USING IMAGING AND BIOMARKERS IN THE AD NEUROIMAGING INITIATIVE (ADNI)", G5386252567, G544148272, A GENOME-WIDE ASSOCIATION DATABASE OF THE ROTTERDAM STUDY, G5479317095, Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults, G5588026468, Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's Disease, G5639648894, Dissecting genetic complexity of Alzheimer's disease and cognitive function, MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults, G567847597, G5702163051, Alzheimer's Disease Neuroimaging Initiative, G5771282042, G5778869478, G5780067080, G5789161078, CHARGE consortium: omics discovery for CVD and aging phenotypes, Alzheimer's Disease Core Center, G5976027236, CHS Events Follow-up Study, G6033034647, Epidemiology of Familial Late-Onset Alzheimer's Disease, G6091493096, Consortium for Alzheimers Sequence Analysis (CASA), Sequence-based Discovery of AD Risk & Protective Alleles, Alzheimer's Disease Research Center - Overall, Building Research Infrastructure & Network in Chicago Chinatown, G6195637971, G6258606120, Development and Use of Network Infrastructure for High-Throughput GWA Studies, G639043084, G6425121803, Wisconsin Alzheimer's Disease Research Center, G6467211887, G6504211364, University of Kansas Alzheimer's Disease Core Centers, G6552090923, Next Generation gene discovery in neurogenetics, G6647076547, G6706757010, G6708752960, ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5, ARIC Neurocognitive Study (ARIC-NCS), G6876577119, THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195, Alzheimer's Disease Research Center, Mechanisms of Small Vessel Related Brain Damage and Cognitive Impairment, Alzheimer Disease Research Center, Genome wide association study of gene expression levels in Alzheimer's disease, Yale Alzheimer Disease Research Center, Arizona Alzheimer's Disease Core Center, G7051404557, Johns Hopkins Alzheimer's Disease Research Center, G7172061274, G7185013638, G7217924807, G7244861316, G7252003062, MRI white matter abnormalities in the elderly: Genetic risk factors, rate of progression and neuropsychologic consequences, G7406331046, G7408940807, G7415749889, A Systems Approach to Targeting Innate Immunity in AD, G7603769780, Boston University Alzheimer's Disease Center, Alzheimer's Disease Research Center, Massachusetts Alzheimer's Disease Research Center, G764651519, G766700449, G766843672, Exceptional Survival: Trajectories to Functional Aging (CHS All Stars), G770899802, The ARIC and Neurocognitive Longitudinal Study, G781162660, G7821523698, Alzheimer's Disease Core Center, Sequence-based Discovery of AD Risk & Protective Alleles, G7955974312, Emory Alzheimer's Disease Center, G806768229, G8068269535, University of Florida - Mt. Sinai Medical Center AD Research Center, Genetic Epidemiological Studies of Alzheimer Disease, G8213835172, G8260701975, Genetics of Parkonsonism, Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD), AD Gene Discovery: Exome Chip, New Endophenotypes & Functional Studies in CHARGE, Statistical and computational methods for integrative analysis of Alzheimer's Disease genetics, G8492131798, G8506930532, COGNITIVE TESTS, APOE, BRAIN MRI AND RISKS OF DEMENTIA, Identification and characterization of AD risk networks using multi-dimensional "omics" data, G8626781164, CHS-Transition Phase -268055222, G8683204365, G8892155751, Building on GWAS for NHLBI-disease: the CHARGE consortium, G890705022, G9000027259, G9000046001, G9000069887, G9000074849, G9000122335, G9000124008, G9000124674, G9000139054, G9000155215, G9000281821, THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE, ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028, New Approaches to Dementia Heterogeneity, Precursors of Stroke Incidence and Prognosis, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Massachusetts Alzheimer's Disease Research Center (MADRC), G905887895, New Approaches to Dementia Heterogeneity, G919295597, G920654007, Mayo Alzheimer's Disease Research Center, G979295734, G980935736
OpenAlex ID: W3149537993
FWCI: 1.904
Cites: 66
Cited by: 36
Related to: 9